{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T15:23:42Z","timestamp":1765812222670,"version":"3.48.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,15]]},"DOI":"10.7759\/cureus.99287","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T15:20:11Z","timestamp":1765812011000},"source":"Crossref","is-referenced-by-count":0,"title":["Use of Intravenous Clevidipine in the Management of Severe Preeclampsia: A Case Report"],"prefix":"10.7759","author":[{"given":"Cody","family":"Brazeal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00070-7","article-title":"Pre-eclampsia","volume":"387","author":"Mol BW","year":"2016","unstructured":"Mol BW, Roberts CT, Thangaratinam S, Magee LA, de Groot CJ, Hofmeyr GJ. Pre-eclampsia. Lancet. 2016, 387:999-1011. 10.1016\/S0140-6736(15)00070-7","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222","volume":"135","author":"American College of Obstetricians and Gynecologists.","year":"2020","unstructured":"American College of Obstetricians and Gynecologists.. Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222. Obstet Gynecol. 2020, 135:e237-60. 10.1097\/AOG.0000000000003891","journal-title":"Obstet Gynecol"},{"key":"ref3","unstructured":"Cleviprex (clevidipine) Injection - Prescribing Information, FDA. (2021). Accessed. December 15, 2025: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/022156s007lbl.pdf."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1213\/ane.0b013e31818240db","article-title":"The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients","volume":"107","author":"Aronson S","year":"2008","unstructured":"Aronson S, Dyke CM, Stierer KA, et al.. The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. Anesth Analg. 2008, 107:1110-21. 10.1213\/ane.0b013e31818240db","journal-title":"Anesth Analg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2021.2002845","article-title":"The impact of pregnancy on antihypertensive drug metabolism and pharmacokinetics: current status and future directions","volume":"17","author":"Mulrenin IR","year":"2021","unstructured":"Mulrenin IR, Garcia JE, Fashe MM, Loop MS, Daubert MA, Urrutia RP, Lee CR. The impact of pregnancy on antihypertensive drug metabolism and pharmacokinetics: current status and future directions. Expert Opin Drug Metab Toxicol. 2021, 17:1261-79. 10.1080\/17425255.2021.2002845","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2022.2129005","article-title":"A review on the clinical pharmacokinetics of hydralazine","volume":"18","author":"Shahzad Qamar A","year":"2022","unstructured":"Shahzad Qamar A, Zamir A, Khalid S, et al.. A review on the clinical pharmacokinetics of hydralazine. Expert Opin Drug Metab Toxicol. 2022, 18:707-14. 10.1080\/17425255.2022.2129005","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-022-03382-3","article-title":"Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review","volume":"78","author":"van de Vusse D","year":"2022","unstructured":"van de Vusse D, Mian P, Schoenmakers S, Flint RB, Visser W, Allegaert K, Versmissen J. Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review. Eur J Clin Pharmacol. 2022, 78:1763-76. 10.1007\/s00228-022-03382-3","journal-title":"Eur J Clin Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2015.12.005","article-title":"Understanding the new FDA pregnancy and lactation labeling rules","volume":"2","author":"Blattner CM","year":"2016","unstructured":"Blattner CM, Danesh M, Safaee M, Murase JE. Understanding the new FDA pregnancy and lactation labeling rules. Int J Womens Dermatol. 2016, 2:5-7. 10.1016\/j.ijwd.2015.12.005","journal-title":"Int J Womens Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.crwh.2023.e00569","article-title":"Postpartum subarachnoid hemorrhage - questions on gestational hypertension diagnosis and treatment threshold: a case report","volume":"40","author":"King-Nakaoka EA","year":"2023","unstructured":"King-Nakaoka EA, Beasley HM, Kessinger SR, Pfeiffer DC. Postpartum subarachnoid hemorrhage - questions on gestational hypertension diagnosis and treatment threshold: a case report. Case Rep Womens Health. 2023, 40:e00569. 10.1016\/j.crwh.2023.e00569","journal-title":"Case Rep Womens Health"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1029\/WFSA-D-18-00020","article-title":"Obstetric and foetal physiology - implications for clinical practice in obstetric analgesia and anaesthesia","author":"Chan YK","year":"2019","unstructured":"Chan YK, Yim CCW. Obstetric and foetal physiology - implications for clinical practice in obstetric analgesia and anaesthesia. WFSA Update Anaesth. 2019, 10.1029\/WFSA-D-18-00020","journal-title":"WFSA Update Anaesth"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/388644-use-of-intravenous-clevidipine-in-the-management-of-severe-preeclampsia-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T15:20:14Z","timestamp":1765812014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/388644-use-of-intravenous-clevidipine-in-the-management-of-severe-preeclampsia-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.99287","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,15]]}}}